Germ-line NF2 mutations and disease severity in neurofibromatosis type 2 patients with retinal abnormalities [7]

American Journal of Human Genetics

Volumn 64, Issue 4, 1999, Pages 1230-1233

  Baser, M E ^a   Kluwe, L ^a   Mautner, V F ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CLINICAL ARTICLE; DISEASE SEVERITY; EYE MALFORMATION; FEMALE; GERM LINE; HAMARTOMA; HUMAN; LETTER; MALE; MISSENSE MUTATION; NEUROFIBROMATOSIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0033358601     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302338     Document Type: Letter

References (19)

1. ME Baser VF Mautner NK Ragge A Nechiporuk VM Riccardi J Klein J Sainz Presymptomatic diagnosis of neurofibromatosis 2 using linked genetic markers, neuroimaging, and ocular examinations Neurology 47 1996 a 1269 1277
2. ME Baser NK Ragge VM Riccardi T Janus B Ganz S Pulst Phenotypic variability in monozygotic twins with neurofibromatosis 2 Am J Med Genet 64 1996 b 563 567
3. EA Bouzas DM Parry R Eldridge MI Kaiser-Kupfer Familial occurrence of combined pigment epithelial and retinal hamartomas associated with neurofibromatosis 2 Retina 12 1992 103 107
4. DGR Evans SM Huson D Donnai W Neary V Blair V Newton R Harris A clinical study of type 2 neurofibromatosis Q J Med 84 1992 603 618
5. DGR Evans L Trueman A Wallace T Strachan Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease caused by truncating mutations J Med Genet 35 1998 450 455
6. DH Gutmann A Aylsworth JC Carey B Korf J Marks RE Pyeritz A Rubenstein The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromtaosis 2 JAMA 278 1997 51 57
7. LB Jacoby M MacCollin DN Louis T Mohney MP Rubio K Pulaski JA Trofatter Exon scanning for mutation of the NF2 gene in schwannomas Hum Mol Genet 3 1994 413 419
8. LD Kaye AD Rothner GR Beauchamp SM Meyers ML Estes Ocular findings associated with neurofibromatosis type II Ophthalmology 99 1992 1424 1429
9. L Kluwe S Beyer ME Baser W Hazim W Haase C Fünsterer VF Mautner Identification of NF2 germ-line mutations and comparison with NF2 phenotypes Hum Genet 98 1996 534 538
10. L Kluwe M MacCollin M Tatagiba S Thomas W Hazim W Haase V-F Mautner Phenotypic variability associated with 14 splice-site mutations in the NF2 gene Am J Med Genet 77 1998 228 233
11. V Mautner M Lindenau ME Baser W Hazim M Tatagiba W Haase M Samii The neuroimaging and clinical spectrum of neurofibromatosis 2 Neurosurgery 38 1996 880 886
12. SM Meyers FA Gutman LD Kaye AD Rothner Retinal changes associated with neurofibromatosis 2 Trans Am Ophthalmol Soc 93 1995 245 252
13. DM Parry R Eldridge MI Kaiser-Kupfer EA Bouzas A Pikus N Patronas Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity Am J Med Genet 52 1994 450 461
14. DM Parry MM MacCollin MI Kaiser-Kupfer K Pulaski HS Nicholson M Bolesta R Eldridge Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities Am J Hum Genet 59 1996 529 539
15. NK Ragge ME Baser J Klein A Nechiporuk J Sainz SM Pulst VM Riccardi Ocular abnormalities in neurofibromatosis 2 Am J Ophthalmol 120 1995 634 641
16. MH Ruttledge AA Andermann CM Phelan JO Claudio F Han N Chretien S Rangaratnam Type of mutation in the neurofibromatosis type 2 gene ( NF2 ) frequently determines severity of disease Am J Hum Genet 59 1996 331 342
17. J Sainz K Figueroa ME Baser VF Mautner SM Pulst High frequency of nonsense mutations in the NF2 gene caused by C to T transitions in five CGA codons Hum Mol Genet 4 1995 137 139
18. DR Scoles ME Baser SM Pulst A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes Neurology 47 1996 544 546
19. IE Zimmer-Galler DM Robertson Long-term observation of retinal lesions in tuberous sclerosis Am J Ophthalmol 119 1995 318 324